Molina Healthcare (NYSE:MOH) had its price target lifted by equities researchers at Piper Jaffray Companies to $92.00 in a note issued to investors on Tuesday. The brokerage currently has an “overweight” rating on the stock. Piper Jaffray Companies’ target price points to a potential upside of 19.06% from the company’s current price.
A number of other equities analysts have also commented on MOH. JPMorgan Chase & Co. upgraded shares of Molina Healthcare from a “neutral” rating to an “overweight” rating in a report on Tuesday, January 16th. Leerink Swann lifted their price target on shares of Molina Healthcare from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, January 9th. Morgan Stanley cut their price target on shares of Molina Healthcare from $97.00 to $94.00 and set an “overweight” rating on the stock in a report on Wednesday, February 7th. ValuEngine lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Finally, Goldman Sachs began coverage on shares of Molina Healthcare in a report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $76.67.
Shares of Molina Healthcare (NYSE:MOH) traded up $0.41 during trading on Tuesday, reaching $77.27. 205,212 shares of the company’s stock were exchanged, compared to its average volume of 1,296,300. Molina Healthcare has a 1 year low of $42.56 and a 1 year high of $93.98. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a market capitalization of $4,588.83, a price-to-earnings ratio of -8.56, a P/E/G ratio of 1.36 and a beta of 1.28.
Molina Healthcare (NYSE:MOH) last issued its earnings results on Monday, February 12th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.11. Molina Healthcare had a negative net margin of 2.58% and a positive return on equity of 17.64%. The firm had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.96 billion. research analysts expect that Molina Healthcare will post 3.68 earnings per share for the current year.
In related news, Director John C. Molina sold 19,433 shares of the business’s stock in a transaction on Wednesday, December 27th. The shares were sold at an average price of $77.22, for a total value of $1,500,616.26. Following the transaction, the director now owns 414,915 shares in the company, valued at $32,039,736.30. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director John C. Molina sold 5,385 shares of the business’s stock in a transaction on Friday, January 26th. The shares were sold at an average price of $92.88, for a total transaction of $500,158.80. Following the completion of the transaction, the director now owns 414,151 shares in the company, valued at approximately $38,466,344.88. The disclosure for this sale can be found here. In the last 90 days, insiders sold 359,890 shares of company stock worth $30,160,285. 6.20% of the stock is owned by company insiders.
Hedge funds have recently added to or reduced their stakes in the stock. Cambridge Investment Research Advisors Inc. increased its stake in Molina Healthcare by 12.4% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 10,067 shares of the company’s stock valued at $772,000 after purchasing an additional 1,109 shares in the last quarter. Xact Kapitalforvaltning AB bought a new stake in Molina Healthcare in the fourth quarter valued at $310,000. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp increased its stake in Molina Healthcare by 17.5% in the fourth quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp now owns 199,500 shares of the company’s stock valued at $15,298,000 after purchasing an additional 29,700 shares in the last quarter. MetLife Investment Advisors LLC bought a new stake in Molina Healthcare in the fourth quarter valued at $3,653,000. Finally, Vident Investment Advisory LLC increased its stake in Molina Healthcare by 6.5% in the fourth quarter. Vident Investment Advisory LLC now owns 32,296 shares of the company’s stock valued at $2,476,000 after purchasing an additional 1,969 shares in the last quarter. Institutional investors and hedge funds own 96.22% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Molina Healthcare (MOH) PT Raised to $92.00” was published by Stock Observer and is the property of of Stock Observer. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.thestockobserver.com/2018/03/20/molina-healthcare-moh-pt-raised-to-92-00.html.
Molina Healthcare Company Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.